TCR-T cell therapy for solid tumors: challenges and emerging solutions
With the use of T cell receptor T cells (TCR-T cells) and chimeric antigen receptor T cells (CAR-T cells), T-cell immunotherapy for cancer has advanced significantly in recent years. CAR-T cell therapy has demonstrated extraordinary success when used to treat hematologic malignancies. Nevertheless,...
| Published in: | Frontiers in Pharmacology |
|---|---|
| Main Authors: | Wanjun He, Kai Cui, Muhammad Asad Farooq, Na Huang, Songshan Zhu, Dan Jiang, Xiqian Zhang, Jian Chen, Yinxia Liu, Guangxian Xu |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1493346/full |
Similar Items
Breaking Bottlenecks for the TCR Therapy of Cancer
by: Lena Gaissmaier, et al.
Published: (2020-09-01)
by: Lena Gaissmaier, et al.
Published: (2020-09-01)
The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses
by: Diana Campillo-Davo, et al.
Published: (2020-07-01)
by: Diana Campillo-Davo, et al.
Published: (2020-07-01)
Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
by: Paul Shafer, et al.
Published: (2022-03-01)
by: Paul Shafer, et al.
Published: (2022-03-01)
TCR T cells overexpressing c-Jun have better functionality with improved tumor infiltration and persistence in hepatocellular carcinoma
by: Mohamed S. Hussein, et al.
Published: (2023-05-01)
by: Mohamed S. Hussein, et al.
Published: (2023-05-01)
pyTCR: A comprehensive and scalable solution for TCR-Seq data analysis to facilitate reproducibility and rigor of immunogenomics research
by: Kerui Peng, et al.
Published: (2022-10-01)
by: Kerui Peng, et al.
Published: (2022-10-01)
Mathematical models of TCR initial triggering
by: Jiawei Shi, et al.
Published: (2024-07-01)
by: Jiawei Shi, et al.
Published: (2024-07-01)
Clonal Analysis of Peripheral Blood T Cells in patients with Hashimoto's Thyroiditis at Different Stages using TCR Sequencing
by: Yufeng Liu, et al.
Published: (2025-05-01)
by: Yufeng Liu, et al.
Published: (2025-05-01)
Human γδ TCR Repertoires in Health and Disease
by: Alina Suzann Fichtner, et al.
Published: (2020-03-01)
by: Alina Suzann Fichtner, et al.
Published: (2020-03-01)
Exploitation of CD3ζ to enhance TCR expression levels and antigen-specific T cell function
by: Abdullah Degirmencay, et al.
Published: (2024-05-01)
by: Abdullah Degirmencay, et al.
Published: (2024-05-01)
Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy
by: Isabella Elias Yonezawa Ogusuku, et al.
Published: (2024-06-01)
by: Isabella Elias Yonezawa Ogusuku, et al.
Published: (2024-06-01)
Modifications outside CDR1, 2 and 3 of the TCR variable β domain increase TCR expression and antigen-specific function
by: Abdullah Degirmencay, et al.
Published: (2023-04-01)
by: Abdullah Degirmencay, et al.
Published: (2023-04-01)
Orthotopic T-Cell Receptor Replacement—An “Enabler” for TCR-Based Therapies
by: Kilian Schober, et al.
Published: (2020-06-01)
by: Kilian Schober, et al.
Published: (2020-06-01)
Deciphering the deterministic role of TCR signaling in T cell fate determination
by: Zhen Qin, et al.
Published: (2025-05-01)
by: Zhen Qin, et al.
Published: (2025-05-01)
TCR-T cell therapy: current development approaches, preclinical evaluation, and perspectives on regulatory challenges
by: Elena A. Golikova, et al.
Published: (2024-10-01)
by: Elena A. Golikova, et al.
Published: (2024-10-01)
Detection of mutant antigen-specific T cell receptors against multiple myeloma for T cell engineering
by: Masahiro Okada, et al.
Published: (2023-06-01)
by: Masahiro Okada, et al.
Published: (2023-06-01)
Exploiting TCR Repertoire Analysis to Select Therapeutic TCRs for Cancer Immunotherapy
by: Ursule M. Demaël, et al.
Published: (2025-08-01)
by: Ursule M. Demaël, et al.
Published: (2025-08-01)
TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors
by: Alaa Alsalloum, et al.
Published: (2023-10-01)
by: Alaa Alsalloum, et al.
Published: (2023-10-01)
TCR-like antibodies in cancer immunotherapy
by: Qinghua He, et al.
Published: (2019-09-01)
by: Qinghua He, et al.
Published: (2019-09-01)
Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy
by: Weihuan Shao, et al.
Published: (2024-04-01)
by: Weihuan Shao, et al.
Published: (2024-04-01)
Integrating Experiment and Theory to Understand TCR-pMHC Dynamics
by: Ashley M. Buckle, et al.
Published: (2018-12-01)
by: Ashley M. Buckle, et al.
Published: (2018-12-01)
Adoptive cell therapy for cancer: combination strategies and biomarkers
by: Shiyu Liu, et al.
Published: (2025-08-01)
by: Shiyu Liu, et al.
Published: (2025-08-01)
Analysis of tumor-related features of non-small cell lung cancer based on TCR repertoire workflow
by: ZHAO Zhuoming, et al.
Published: (2023-12-01)
by: ZHAO Zhuoming, et al.
Published: (2023-12-01)
Adoptive T cell therapy for solid tumors: current landscape and future challenges
by: Víctor Albarrán, et al.
Published: (2024-03-01)
by: Víctor Albarrán, et al.
Published: (2024-03-01)
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
by: Jiangping Li, et al.
Published: (2023-08-01)
by: Jiangping Li, et al.
Published: (2023-08-01)
Case Report: An unclassified T cell lymphoma subtype with co-expression of TCR αβ and γ chains revealed by single cell sequencing
by: Wei Song, et al.
Published: (2023-05-01)
by: Wei Song, et al.
Published: (2023-05-01)
Adoptive Cellular Therapy for Multiple Myeloma Using CAR- and TCR-Transgenic T Cells: Response and Resistance
by: Franziska Füchsl, et al.
Published: (2022-01-01)
by: Franziska Füchsl, et al.
Published: (2022-01-01)
The recent advancement of TCR-T cell therapies for cancer treatment
by: Zhao Xiang, et al.
Published: (2024-04-01)
by: Zhao Xiang, et al.
Published: (2024-04-01)
TCRscape: a single-cell multi-omic TCR profiling toolkit
by: Roman Perik-Zavodskii, et al.
Published: (2025-09-01)
by: Roman Perik-Zavodskii, et al.
Published: (2025-09-01)
A comprehensive evaluation of diversity measures for TCR repertoire profiling
by: Justyna Mika, et al.
Published: (2025-05-01)
by: Justyna Mika, et al.
Published: (2025-05-01)
Distinct T-cell receptor (TCR) gene segment usage and MHC-restriction between foetal and adult thymus
by: Jasmine Rowell, et al.
Published: (2024-12-01)
by: Jasmine Rowell, et al.
Published: (2024-12-01)
Evolution of CD8<sup>+</sup> T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer
by: Yimo Sun, et al.
Published: (2021-09-01)
by: Yimo Sun, et al.
Published: (2021-09-01)
A Cysteine Residue within the Kinase Domain of Zap70 Regulates Lck Activity and Proximal TCR Signaling
by: Annika Schultz, et al.
Published: (2022-09-01)
by: Annika Schultz, et al.
Published: (2022-09-01)
Structural basis of the TCR-pHLA complex provides insights into the unconventional recognition of CDR3β in TCR cross-reactivity and alloreactivity
by: Dan San, et al.
Published: (2023-02-01)
by: Dan San, et al.
Published: (2023-02-01)
The main steps of TCR signalingNegative times negative equals positive, THEMIS sets the rule on thymic selection and peripheral T cell responses
by: Suzanne Mélique, et al.
Published: (2022-04-01)
by: Suzanne Mélique, et al.
Published: (2022-04-01)
Immunotherapy with adoptive cytomegalovirus‐specific T cells transfer: Summarizing latest gene engineering techniques
by: Mahshid Mehdizadeh, et al.
Published: (2021-09-01)
by: Mahshid Mehdizadeh, et al.
Published: (2021-09-01)
Unique features of the TCR repertoire of reactivated memory T cells in the experimental mouse tumor model
by: Anastasiia Kalinina, et al.
Published: (2023-01-01)
by: Anastasiia Kalinina, et al.
Published: (2023-01-01)
T-cell receptor signaling modulated by the co-receptors: Potential targets for stroke treatment
by: Yuanyuan Liu, et al.
Published: (2023-06-01)
by: Yuanyuan Liu, et al.
Published: (2023-06-01)
Autophagic flux restoration of senescent T cells improves antitumor activity of TCR‐engineered T cells
by: Chaoting Zhang, et al.
Published: (2022-01-01)
by: Chaoting Zhang, et al.
Published: (2022-01-01)
Huge overlap of individual TCR beta repertoires
by: Mikhail eShugay, et al.
Published: (2013-12-01)
by: Mikhail eShugay, et al.
Published: (2013-12-01)
T-Cell Gene Therapy in Cancer Immunotherapy: Why It Is No Longer Just CARs on The Road
by: Michael D. Crowther, et al.
Published: (2020-06-01)
by: Michael D. Crowther, et al.
Published: (2020-06-01)
Similar Items
-
Breaking Bottlenecks for the TCR Therapy of Cancer
by: Lena Gaissmaier, et al.
Published: (2020-09-01) -
The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses
by: Diana Campillo-Davo, et al.
Published: (2020-07-01) -
Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
by: Paul Shafer, et al.
Published: (2022-03-01) -
TCR T cells overexpressing c-Jun have better functionality with improved tumor infiltration and persistence in hepatocellular carcinoma
by: Mohamed S. Hussein, et al.
Published: (2023-05-01) -
pyTCR: A comprehensive and scalable solution for TCR-Seq data analysis to facilitate reproducibility and rigor of immunogenomics research
by: Kerui Peng, et al.
Published: (2022-10-01)
